Local-regional approach to diffuse malignant peritoneal mesothelioma.
作者信息
Sugarbaker Paul H
出版信息
Gastroenterol Clin Biol. 2007 Oct;31(10):780-1. doi: 10.1016/s0399-8320(07)73963-5.
Abstract
摘要
相似文献
1
Local-regional approach to diffuse malignant peritoneal mesothelioma.
Gastroenterol Clin Biol. 2007 Oct;31(10):780-1. doi: 10.1016/s0399-8320(07)73963-5.
2
Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy.
Gastroenterol Clin Biol. 2007 Oct;31(10):784-8. doi: 10.1016/s0399-8320(07)73964-7.
3
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Ann Surg Oncol. 2006 Feb;13(2):229-37. doi: 10.1245/ASO.2006.03.045. Epub 2006 Jan 18.
4
Peritoneal mesothelioma.
Curr Treat Options Oncol. 2000 Oct;1(4):303-12. doi: 10.1007/s11864-000-0046-5.
5
HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.
Cancer Treat Res. 2007;134:303-18. doi: 10.1007/978-0-387-48993-3_19.
6
Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12.
7
The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol. 2013 Apr;20(4):1093-100. doi: 10.1245/s10434-012-2845-x. Epub 2013 Mar 2.
8
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Ann Surg Oncol. 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0. Epub 2013 Mar 17.
9
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Ann Surg Oncol. 2018 Mar;25(3):667-673. doi: 10.1245/s10434-017-6293-5. Epub 2017 Dec 19.
10
Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
Ann Surg Oncol. 2010 Jun;17(6):1710-2; author reply 1713-4. doi: 10.1245/s10434-010-1042-z.
引用本文的文献
1
Peritoneal mesothelioma.
Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8.
Zotero 插件